ethidium bromide has been researched along with bibr 1532 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, C; Jia, YM; Li, J; Liu, XH; Song, BA; Wu, XQ | 1 |
| Li, R; Liu, XH; Qi, XB; Shi, JB; Tang, WJ | 1 |
| Huang, YJ; Liu, XH; Qi, XB; Song, BA; Xue, W; Zhao, HJ | 1 |
3 other study(ies) available for ethidium bromide and bibr 1532
| Article | Year |
|---|---|
Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Coumarins; Drug Design; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Magnetic Resonance Spectroscopy; Molecular Docking Simulation; Pyrazoles; Sulfhydryl Compounds | 2014 |
Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity.
Topics: Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Structure; Pyrazoles; Pyrimidines; Structure-Activity Relationship | 2015 |
Novel myricetin derivatives: Design, synthesis and anticancer activity.
Topics: Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Drug Design; Flavonoids; Humans; Molecular Docking Simulation; Molecular Structure | 2015 |